We investigated differences in the expression of RhoA mRNA in PBMCs between patients with SLE and healthy controls by quantitative, real-time PCR (RT-PCR) and observed a 3-fold higher level of RhoA mRNA in the lupus group (Fig. 1A). This evidence concerns the gene RHOA and systemic lupus erythematosus.